A federal judge has issued an injunction suspending the Food and Drug Administration's (FDA) approval of the abortion pill mifepristone, potentially impacting access to medication abortions nationwide. U.S. District Judge Matthew Kacsmaryk ruled that the FDA's two-decade-old approval of the drug violated a federal rule and was unlawful. The government has a week to appeal the decision, which could have far-reaching implications for abortion access in the United States.
